Access cutting-edge chronic inflammatory demyelinating polyradiculoneuropathy treatment through this clinical trial at a research site in Wilmington. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Wilmington location
Preparing your pre-screening questions…
Access chronic inflammatory demyelinating polyradiculoneuropathy specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic inflammatory demyelinating polyradiculoneuropathy treatment provided free
Check if you qualify for this chronic inflammatory demyelinating polyradiculoneuropathy clinical trial in Wilmington, NC
No-Cost Study Care
Local to Wilmington
Convenient for NC residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The aims of this study are to assess the real-world effectiveness of efgartigimod in treating chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), describe the "treatment journey" of participants with CIDP, and assess the utilization of health care services among adult participants with CIDP who initiate treatment with efgartigimod. As this is a noninterventional study, treatment choices and decisions will be left to the discretion of participants and their physicians, according to the standard of care. Each participant will be prospectively followed for up to 2 years from the date of initial administration of efgartigimod.
Sponsor: argenx
Yes, this clinical trial (NCT07264426) has an active research site in Wilmington, NC that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for chronic inflammatory demyelinating polyradiculoneuropathy treatment options in Wilmington, NC, this clinical trial (NCT07264426) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Wilmington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic inflammatory demyelinating polyradiculoneuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all chronic inflammatory demyelinating polyradiculoneuropathy clinical trials near you to find additional studies recruiting in your area.
See all multiple myeloma clinical trials recruiting in Wilmington — not just this study.
Browse Multiple Myeloma Trials in Wilmington →